Podcasts about Nuzzo

Dr. ​​James L. Nuzzo isan exercise scientist and men's health researcher. Dr. Nuzzo has published over 80 research articles in peer-reviewed journals, and he writes regularly about exercise, men's health, and academia at The Nuzzo Letter on Substack. Dr. Nuzzo is also active on X @JamesLNuzzo.James' Substack: https://jameslnuzzo.substack.com/Support the show

Sam is joined by Mike Nuzzo - Course Architect, beer savant and aerospace engineer in a previous life - to talk about all things Cabot Citrus Farms.  Mike was responsible for the Squeeze & the Wedge at the new cabot development, a 10 hole half par course ands the short illuminated par 3 course. Some of the most fun you can pack into 100 acres! We also talk about the history of World Woods, and the work on The Roost which Mike was responsible for. Mike's social can be found hereIf you've enjoyed this episode, please leave us a review on Apple Podcasts or Spotify!You can follow us along below @cookiejargolf Instagram / Facebook / Twitter / YouTube / Website

What's it like serving as a juror? In this episode, Anna Nuzzo shares her personal experience of being selected for jury duty—from navigating the selection process to participating in deliberations and hearing the final verdict. Discover how Anna's Catholic faith shaped her perspective, including her prayers for the convicted individual after the trial. This insightful discussion explores civic duty, the pursuit of justice, and faith in action. Perfect for those curious about the jury process or seeking inspiration on living out faith in everyday life! Lern more about Anna Nuzzo at: https://www.annanuzzo.com

In this episode of the Sustainability Story podcast, host Nicole Gehrig welcomes Dr. Carmen Nuzzo, executive director of the Transition Pathway Initiative Centre (TPI Centre) at the London School of Economics and Political Science. The conversation centers around the TPI Centre's mission as the academic partner of the global investor initiative, highlighting the TPI tools, which provide independent, authoritative research and open-access data on corporate, bank, and sovereign entities' progress in transitioning to a low-carbon economy. Carmen explains how investors can leverage these tools to assess sustainability efforts and make informed decisions in their investment strategies. Join us for insights into the vital role of data in driving sustainable investment practices.

In episode 20 of Psychobabble, we sit down with Dr. James Nuzzo, a published researcher and expert in exercise science and Men's Health, to discuss his widely read paper ““Woke” nomenclature in health research." Dr. Nuzzo shares his first-hand experiences navigating social justice-driven research and battling with peer reviewers who prioritize politics over science. From the frustrations of trying to get published to the broader consequences on patient care, we explore how ideological bias is reshaping scientific research and the pressures academics face for challenging the status quo. Dr. Nuzzo pulls no punches as he reveals the growing risks to research integrity in an increasingly politicized academic world.This is one episode you won't want to miss if you care about the future of evidence-based medicine. Please support Psychobbable by subscribing! Short on time? * 00:00:00: Introduction to Psychobabble and Today's Guest, James Nuzzo* 00:01:00: James Nuzzo's Background in Exercise Science and Academia* 00:02:30: Woke Ideology Infiltrating Medical and Biological Sciences* 00:04:30: The Controversy Around Men's Health Research* 00:06:00: Peer Review Madness: Perception vs. Data* 00:07:30: The Myth of Women Being Underrepresented in Medical Research* 00:09:00: Academic Pushback and the Fight to Publish Men's Health Studies* 00:11:00: Transgender Issues in Exercise Science and Research Bias* 00:14:00: Woke Terminology in Medical Literature: Nuzzo's Findings* 00:19:00: Political Correctness and the Feminization of Universities* 00:24:00: What Needs to Change in Academia and Moving Forward* 00:28:00: Conclusion and How to Support PsychobabbleGet your nails done to perfection and get in shape at this luxury gym while ordering your stunning new custom made art piece for your home with a discount using the promocode “psychobabble podcast” - Check it out by clicking below: Get full access to Psychobabble at hannahspier.substack.com/subscribe

Marc Kapetan sits down with the owner of Mike's Pizzeria and Lounge, Peter Di Nuzzo.   Di Nuzzo shares stories of how the family business got started, what family life is like away from the Pizzeria and what's next for the popular Fresno hot spot.   Please Like, Comment and Follow 'The Marc Kapetan Podcast' on all platforms:   ---    The Marc Kapetan Podcast is available on the KMJNOW app, Apple Podcasts, Spotify, YouTube or wherever else you listen to podcasts.    ---  Kapetan Brothers Law  | Website  | Facebook | YouTube |  -  Everything KMJ   KMJNOW App | Podcasts | Facebook | X | Instagram   See omnystudio.com/listener for privacy information.

CITR's 24 Hours of Radio Art in a snack sized format. Dark Ambient. Drone. Field Recordings. Noise. Sound Art. Or something. This morning's broadcast features phoanøgramma / LUCA FERRO, SANCTUARY, JOHN KEN NUZZO / HAIOKA , and JOEL CHADABE.

Alexandra Marshall Live features exclusive international guests, bringing world affairs to your home. Watch ‘Alexandra Marshall Live' live and on demand at ADH TV, Monday's 9PM AEDT. Learn more about your ad choices. Visit megaphone.fm/adchoices

Ventiduesima puntata di De Core Podcast condotto da Alessandro Pieravanti e Danilo da Fiumicino. Ospiti della puntata: Nuzzo e Di Biase "De Core" sono tutte le cose che ci fanno stare bene: musica, film, viaggi, cibo, sport e chi più ne ha più ne metta. Playlist scelta come brani "De Core" da Corrado e Maria: Enzo Jannacci - Vengo anch'io Rino Gaetano - A mano a mano Skiantos - Mi piaccion le sbarbine Location: Riversider Roma Format di Alessandro Pieravanti e Danilo Contaldo Prodotto da Dopcast Musiche: Matteo Pieravanti Logo: Alessandro Catalano. Learn more about your ad choices. Visit podcastchoices.com/adchoices

This week's episode dives deep into the wonderful world of Dr. Nuzzo. His revolutionary approach to movement, walking, surgery, and all things CP is profound.We love to hear from you. Send emails to ForOurSpecialKids@gmail.com if you have questions, topics, or an amazing person we should highlight. And, please tell a friend or caregiver about us! Follow Us on Instagram & FaceBook, @ForOurSpecialKids or go to https://www.ForOurSpecialKids.comhttps://uppbeat.io/t/lane-king/journeyLicense code: E3DYP1B4L21HSX8E

AMIGOS QUE LOCURA PODER HABER CONECTADO CON LINO DE VERDAD QUE ES UN TIPAZO Y PUES AQUI ESTA LO MÁS LOCO QUE ESTE CRACK HAYA HECHO POR MI, NO SE LO PIERDAN 28/09 #podcastenespañol #podcastinglifeBio: Actor y bailarín de múltiples estilos que ha participado en la segunada temporada de Soy Luna. También formó parte también de algunas películas como Forever Young y Tini, El gran cambio de Violetta, en la serie italiana Don Matteo temporada 12 es todo un artista --- Send in a voice message: https://podcasters.spotify.com/pod/show/cristhian-navarrete/message

In a riveting conversation with researcher Dr. James L Nuzzo, we dissect the differences in skeletal muscle fiber types between men and women. James brings unique insights from his meta-analysis of over 100 studies, unraveling fascinating intricacies about muscle power and strength differences between men and women.  Then, we turn the spotlight on the less examined subject of gender differences in exercise sciences and academia. The absence of discourse on the physiological disparities between men and women, the controversy of transgender females competing against biological females, and the need for a proactive dialogue in this realm are just some of the issues we unpack in this episode.Timeline:0:20 – About Dr. James Nuzzo2:46 - Sex differences in skeletal muscle fiber types; yes, men have more fast-twitch muscle fibers!11:22 – Female exercise scientists – are they silent on the issue of women's sports and transgender athletes? 31:37 – Men's health disparities and institutional support.34:00 - Are women under-represented in scientific research? Meaning, women are not being studied? The data is surprising.45:48 – Reconsidering the value of flexibility About our guest:James L. Nuzzo, Ph.D. is an Adjunct Senior Lecturer in the School of Medical and Health Sciences at Edith Cowan University in Australia. He is the author of over 70 peer-reviewed research articles and the founder of The Nuzzo Letter on Substack. He is active on Twitter @JamesLNuzzo.About the ShowWe cover all things related to sports science, nutrition, and performance. The Sports Science Dudes represent the opinions of the hosts and guests and are not the official opinions of the International Society of Sports Nutrition (ISSN), the Society for Sports Neuroscience, or Nova Southeastern University. The advice provided on this show should not be construed as medical advice and is purely an educational forum.Hosted by Jose Antonio PhDDr. Antonio is the co-founder and CEO of the International Society of Sports Nutrition and the co-founder of the Society for Sports Neuroscience, www.issn.net. Dr. Antonio has over 120 peer-reviewed publications, and 16 books, and is a Professor at Nova Southeastern University, Davie, Florida in the Department of Health and Human Performance.Twitter: @JoseAntonioPhDInstagram: the_issn and supphdCo-host Anthony Ricci EdDDr Ricci is an expert on Fight Sports and an Assistant Professor at Nova Southeastern University in Davie, Florida, in the Department of Health and Human Performance.Instagram: sportpsy_sci_doc and fightshape_ricci

Mike Nuzzo joins us today to discuss his "tie" to the game-One thing I've found common amongst most architects is that for better or worse, golf and architecture consume their thinking. For many, it does result in some extraordinary work. With Mike, I found it refreshing how much he has invested in a well-rounded life. Expect an episode that covers far more than width, angles, and strategy. We spend a good deal of time discussing his background as an aerospace engineer, the components and ratios of a great Cuban sandwich, the best beer in FL, and his daughters professional career as a concert photographer.  Speaking of Florida, Mike is building something very special in Brooksville for Cabot Citrus Farms. We will be covering that more extensively going forward, and for you golf course architecture sickos, expect to be taken DEEP into the weeds. Cheers,- The Tie GuysMike Nuzzo's Website:http://www.mnuzzo.com/Upcoming "The 21" at Cabot Citrus Farmshttps://cabotcitrusfarms.com/golf/the-21Website:https://www.thetiepodcast.comInstagram:https://www.instagram.com/thetiepodcast/?hl=enTwitter:https://mobile.twitter.com/thetiepodcastTikTok:@tieguys @tieguytexasranger @tieguyhs GoodWalk Coffee:https://goodwalkcoffee.comCODE: thetie for 20% offBDraddy:bdraddy.comCODE: thetie25 for 25% off

Join Lara for an introduction to napropathic medicine with Dr. Patrick Nuzzo, DN. Dr. Nuzzo's passion for the restorative, regenerative lifestyle and the anti-inflammatory diet began in 1974 during his nutritionist studies, motivated by the loss of his influential naprapath uncle. He made significant contributions to the natural foods industry, developing renowned nutritional supplements and partnering with notable figures like Walter Payton. In 1983, Dr. Nuzzo graduated as a Doctor of Naprapathic Medicine and successfully managed Naprapathic practices in multiple locations. His efforts led to the introduction of the Naprapathic Practice Act in New Mexico in 2000. This eventually paved the way for the establishment of Southwest University of Naprapathic Medicine (SUNM) in 2010, which became the first accredited school of Naprapathic Medicine in 2021. In this episode, you'll learn about:1. what is napropathy and what is its history.2. the importance of opening pathways in the body to heal.3. the impact of trauma on the body, particularly in early childhood.4. about the regenerative lifestyle and anti-inflammatory medicine.5. about the triumphs and challenges of establishing napropathy as a legitimate field of study and practice.To learn more, and for the complete show notes, visit: lytyoga.com/blog/category/podcasts/Guest Resources:Southwest University of Naprapathic Medicine - sunm.eduNaprapathic Medicine of New Mexico - nmnm.orgInstagram - @sunmeduFacebook - https://www.facebook.com/SouthwestUniversityofNaprapathicMedicineDr. Nuzzo's Book - Anti-Inflammatory Medicine: Naprapathy & Nutrition for a Healthy, Regenerative Lifestyle https://a.co/d/jkMFxssConnect with Lara Heimann, The Redefining Yoga Podcast, and LYT Yoga:Lara Heimann Instagram - https://www.instagram.com/lara.heimann/ Redefining Yoga Instagram - https://www.instagram.com/redefiningyogapodcast/ LYT Yoga Instagram - https://www.instagram.com/lytyogamethod/Sponsors:Visit relationshipschool.com/lara to get 50% off your first month of relationship coaching.Visit herbalfacefood.com and use code Lara20 for 20% off! Hosted on Acast. See acast.com/privacy for more information.

In today's episode of the podcast, Matt is joined by Carley Nuzzo, whose company is mentor focussed and works with kids. Her goal is to take away as much stress and pressure as possible off of families by being a resource. Kind of like a "Middle-man". Sometimes outside voices are needed to help kids reach their potential! Learn about today's challenging academic climate and how college admission has changed. Dive into the episode! Welcome back to the Get Better Everyday Podcast! Tune-in to find out - Welcome back to the Get Better Everyday Podcast! Want to help the show? Sharing this episode with a friend or on social media is the number 1 way to help us grow. Leaving 5-star reviews on Spotify and Apple Podcasts are also great ways to give back. Visit mattgouge.com to learn more! Follow Carley on Instagram @esmprep --- Send in a voice message: https://podcasters.spotify.com/pod/show/matt-gouge/message

In this episode of the Parousia Podcast, Charbel Raish talks to Catholic singer/songwriter Anna Nuzzo about her Australian Tour 'Limitless' and her amazing music ministry. https://www.annanuzzo.com/ Join the Parousia mailing list at https://www.parousiamedia.com/mailing... Parousia is committed to proclaiming the fullness of truth! If you wish to help us in our mission with a donation please visit our website here https://www.parousiamedia.com/donate/ to learn ways that you can contribute.

Anna Nuzzo is a renowned International Catholic Singer, Songwriter and Recording Artist. On the Feast Day of Our Lady of the Rosary in 2012, she consecrated her life to Jesus through Mary. This was a major blessing and turning point in her life, jumpstarting her global Music Ministry! Through her Marian Consecration, our Lady enkindled in her a tremendous desire and ability to evangelize through her music, without fear and anxiety. She now felt “limitless” and empowered to truly share her God-given gifts, being “a true instrument” for God! This was the beginning of a whole new life ~ a life of travel and Evangelization by composing and sharing her prayer songs around the world. Through her in-person special events and 6 albums (available on all digital streaming platforms and CD), she is well-known for elevating prayer through her beautiful and inspiring music. Anna has a beautiful variety of things you can buy such as her prayer pouches and CD's https://youtu.be/xGGQe89nF_k

Professor Jennifer Nuzzo, Brown University SPH Pandemic Center, reflects on the recent March 28 hearing that the House Select Subcommittee on the Coronavirus Pandemic staged on school closures. The subject remains “a political football.”  But “we now better understand the potential harms. We have not all suffered the same harms.” Progress possible? Not clear, given how toxic the politics has become. Need to “take down the heat.” “We need a national plan for schools' recovery.”

On this episode of Infectious, we interview Dr. Jennifer Nuzzo, a Professor of Epidemiology and the Director of the Pandemic Center at Brown University. She's also a Senior Fellow for Global Health at the Council of Foreign Relations and co-leads the Outbreak Observatory. We discuss the state of the pandemic and the effects of Covid-19 on other diseases. Comments or Questions? Leave them below:https://forms.gle/hxFV8Pg6tpAyVoJh8

È più divertente la verità o la finzione? È meglio elaborare ciò che vediamo o creare cose che non esistono? E se la finzione poi plasma la realtà? In questo panel un gruppo di professionist della scrittura comica cercherà di indagare su come gestire l'ironia e il sarcasmo senza aumentare la disinformazione, in un mondo di meme che fa sempre più fatica a distinguere ciò che è vero, da ciò che è falso.Ospiti: Francesco De Carlo, Maria Di Biase e Corrado Nuzzo, Daniele Fabbri, Francesco Lancia, Saverio Raimondo - modera Chiara Galeazzi Redazione: Elisa Baioni, Diego Martin, Alex Ordiner, Chiara Vitaloni, Dasara Shullani, Enrico Zabeo, Cecilia Penelope ZambelliGrafica e Logo: Fabio MialichSigla ed effetti: https://www.zapsplat.com/ ZapsplatMusiche: https://www.epidemicsound.com/ Epidemic SoundSeguiteci sui profili social del CICAP:Facebook: @cicap.orgTwitter: @cicapInstagram: cicap_it

From childhood poverty to addiction in multiple forms, depression, and a global pandemic Vinny Nuzzo has been tried and tested his whole life.Michelle and Vinny connected because of a vulnerable LinkedIn post. In this episode he shares his story of pivotal experiences that shaped his life and the revelations and decisions to go a new direction. Connect with Vinny:stressundone.comIG: @mr_stress_undoneConnect with us:betterbeings.netIG: @be.a.better.beingMichelle: @betterbeingsusSasha: @sasha.patriciaYouTube: Michelle Zellner - Be A Better Being Podcast playlist

In today's episode, we speak with Patrick Nuzzo, an alternative medicine doctor who's opened five practices including the Southwest University of Naprapathic Medicine and Health Sciences. After spending years formulating nutritional supplements for the natural food industry, Dr. Nuzzo discovered naprapathy—what he sees as the future of health and nutrition. This type of “hands-on” manual medicine involves nutritional counseling and techniques that optimize circulation of the body. Dr. Nuzzo's passion for this treatment made him instrumental in the passing of the Naprapathic Practice Act of New Mexico—allowing naprapaths to practice in the state of New Mexico.Listen as Dr. Nuzzo talks about the difference between naprapathy and physical therapy, developing a sports nutrition line for former NFL great Walter Payton, and why naprapathy is one of the best wellness treatments in natural medicine. 

This Episode we interview Jennifer Nuzzo, Dr. Brett Scott, Nathan & Alex Edwards about their take on being a Gym Owner. Welcome to the Gym Lords Podcast, where we talk with successful gym owners to hear what they're doing that is working RIGHT NOW, and to hear lessons and failures they've learned along the way. We would love to share your story! If you'd like to be featured on the podcast, fill out the form on the link below. https://gymlaunchsecrets.com/podcast

This Episode we interview Jennifer Nuzzo, Dr. Brett Scott, Nathan & Alex Edwards about their take on being a Gym Owner. Welcome to the Gym Lords Podcast, where we talk with successful gym owners to hear what they're doing that is working RIGHT NOW, and to hear lessons and failures they've learned along the way. We would love to share your story! If you'd like to be featured on the podcast, fill out the form on the link below. https://gymlaunchsecrets.com/podcast

In this episode of the Parousia Podcast Charbel Raish speaks to Anna Nuzzo, wife, mother, musician, former television host, Catholic speaker, singer/songwriter and recording artist. Anna tells her story of faith and healing through her Marian consecration. https://www.annanuzzo.com/ Join the Parousia mailing list at https://www.parousiamedia.com/mailing... Parousia is committed to proclaiming the fullness of truth! If you wish to help us in our mission with a donation please visit our website here https://www.parousiamedia.com/donate/ to learn ways that you can contribute.

Hosts Mark Masselli and Margaret Flinter speak with Dr. Jennifer Nuzzo who leads the Pandemic Center at the Brown University School of Public Health; she was initially hired for the role by Dr. Ashish Jha, who is now the White House Coronavirus Response Coordinator. Dr. Nuzzo tells Mark and Margaret that COVID remains a fairly significant health threat, especially in terms of possible variants, but we're not in the same situation we were two years ago. She reacts to President Biden's recent statements about the state of the pandemic and believes one way to assess its end is how people are living today. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Demetre Daskalakis, deputy coordinator of the White House national monkeypox response, and Jeremy Youde, dean of the College of Arts, Humanities, and Social Sciences at the University of Minnesota Duluth, discuss the emergence of monkeypox and other diseases, international responses, and messaging around health issues that especially affect the LGBTQ+ community. Jennifer Nuzzo, senior fellow for global health at CFR, moderates. Learn more about CFR's Religion and Foreign Policy Program. FASKIANOS: Thank you, and welcome to the Council on Foreign Relations Social Justice Webinar series. The purpose of this series is to explore social justice issues and how they shape policy at home and abroad through discourse with members of the faith community. I'm Irina Faskianos, vice president of the National Program and Outreach here at CFR. As a reminder, this webinar is on the record, and it will be made available on CFR's website, CFR.org, and on the iTunes podcast channel, “Religion and Foreign Policy.” As always, CFR takes no institutional positions on matters of policy. We're delighted to have Jennifer Nuzzo, senior fellow for global health at CFR, to moderate today's discussion on infectious diseases. Dr. Nuzzo is a senior fellow for global health here at CFR. She's also a professor of epidemiology and the inaugural director of the Pandemic Center at Brown University's School of Public Health. Her work focuses on global health security, public health preparedness and response, and health systems resilience. In addition to her research, she directs the Outbreak Observatory, which conducts operational research to improve outbreak preparedness and response. And she advises national governments, and for-profit and non-profit organizations on pandemic preparedness and response, and worked tirelessly during the COVID pandemic to advise and tell people what was going on, to the extent that we knew, as we made our way through this two-and-a-half-year pandemic. So, Jennifer, I'm going to turn it over to you to introduce our speakers. NUZZO: Great. Thank you, Irina. Thanks for that introduction and thanks for organizing this webinar today. I'm very glad that we're having this conversation. As someone who's worked in infectious diseases for my entire career, I have found the last few years to be particularly staggering. I was looking, and as of today there are more than 616 million cases of COVID-19 that have been reported globally, upwards of 6.5 million diagnosed deaths that have been reported worldwide. At the same time, we are also seeing a global surge in cases of monkeypox, a disease that many hadn't heard of prior to this past year. And now we are over 66,000 cases that have been reported globally, more than 25,000 of those reported here in the United States alone. At the same time, successive outbreaks of Ebola have been occurring, and we have measles once again on the rise. And now vaccine-derived polio circulating in countries where the virus had been previously thought to be eliminated. So it's really a staggering list of infectious diseases that have been occurring and continue to occur. So clearly, we're at an important crossroads in terms of how we respond to these recurring hazards and infectious disease emergencies. But today we get to zoom out a little bit, and to examine factors that they may have all in common, and to try to understand what may be driving these—the recurrence of these events over and over again. So over the past few years we have seen the consequences of social, economic, and racial inequities play out center stage. These factors have underpinned not only our underlying vulnerabilities to infectious diseases, but also how effectively we respond to them. So that's what we're going to talk about today. And to help discuss these issues we are joined by two globally renowned experts who have a long history in working to address infectious disease threats and the disparities that accelerate them. Our first panelist is Dr. Demetre Daskalakis. Dr. Daskalakis is the deputy coordinator of the White House national monkeypox response. Prior to this role, he served as director of CDC's division of HIV prevention. And prior to that, oversaw infectious diseases for the New York City Department of Health and Mental Hygiene, which is one of the largest health departments in the nation and rivals the WHO in terms of staff and budgets. So Dr. Daskalakis is a leading national expert on many things, but also in particular health issues affecting the LGBTQIA+ communities. And he has worked clinically for much of his career to focus on providing care for these communities. We are also joined by Dr. Jeremy Youde, who is the dean of the College of Arts, Humanities, and Social Sciences at the University of Minnesota Duluth. Previously, Dr. Youde was an associate professor in the department of international relations at Australia National University in Canberra. Dr. Youde is an internationally recognized expert on global health politics. And he is a very prolific writer. He has written five books, and many chapters, and countless articles. I recently read a very compelling blog post by him on our own CFR's Think Global Health. So really excited to get both Dr. Youde and Dr. Daskalakis's perspectives on the issues in front of us. So I will get the conversation started. We have a lot of great attendees, and we'll have time for questions. But just to get the conversation going, let's see here. Maybe first, if I could turn to you, Dr. Demetre. For those who haven't been living in the monkeypox data as much as you have, perhaps you could just give us a quick summary of where we are and where you see us being headed. DASKALAKIS: Thank you. And thank you for having me. I'm really excited to join Jeremy and to be a part of this discussion. So living in the data is, in fact, what I do. So I'll tell you, so monkeypox—I'll give a little key bit of background just for everyone to be level-set—is an orthopoxvirus, that is a virus that causes disease, transmitted usually from animals to humans. Usually, traditionally, not a lot of human-to-human transmission. This current outbreak in 2020, global in scale, with 66,500 cases reported internationally, actually demonstrates pretty good human-to-human transmission, often in the setting of close contact, often associated with sexual activity, and the majority of cases being among men who have sex with men—the vast majority, over 96 percent. In the U.S., at this moment, we have 25,300 cases. I can tell you right up to the moment. And so we continue to see increases in cases in the United States, but we're seeing a deceleration in the rate of increase. So cases are stilling being logged. We used to see kind of around four hundred cases per day. We're now more on the order of two hundred or below and continue to see that trend going in a good direction with more data imminently coming to the website of CDC later on today. Again, just briefly, the demographic, majority male, mainly men who have sex with men—the gay, bisexual, other men who have sex with men. Looking at the demographics, at the beginning of the outbreak in May, the majority of cases were among white men. And now we're seeing about 68 percent of those cases are happening in Latino or Black men. From the perspective of that measure as well we've seen a significant increase in vaccinations. So we can talk—we're going to talk more about that, I'm sure. But really with lots of strategies to increase vaccine supply. We are now well over eight hundred thousand vaccines administered. There is an inequity there as well. The majority of vaccines are going to white men. And we're seeing Latino men and Black men in second and third place, respectively, in terms of vaccines administered. Jennifer, I hope that that's a good situation summary to start off with. NUZZO: Yeah, great summary. Thank you so much. That helped kind of bring everybody to the same—somewhat same level. Just a quick follow-up question for you. There have been a lot of headlines about the important progress we've made, and the fact that the global monkey—or, sorry—the monkeypox cases seem to be coming down in terms of numbers. Question: Are you seeing similar trends for all demographics? Or are you concerned that perhaps the large numbers are hiding increased transmission in other groups? DASKALAKIS: I had to fix the mute. There we go. So I think what we've seen is that the declines are looking to be even across population. So that's good news. Again, the vaccine equity is our main issue right now in terms of where we're—where that's stubborn right now, and really thinking about strategies to improve that. We had a lot of news today, which I'm sure we'll be able to talk about some of the strategies that we have to address that. But so I think there's no clear sign that the deceleration is different in different populations. Geographically, however, it is different. And so that's, I think, one place where—the jurisdictions that have had the greatest and longest experience with this outbreak, so the most cases, are also the jurisdictions that have access to the most vaccines. So whether it's because of behavior change that we're seeing, which is definitely something that we, I imagine, could talk about here as well, or natural infections plus vaccine-induced immunity, I think the places that have had more experience are showing deceleration faster. So New York, California, Texas, and Georgia are looking down, while some of the places where the outbreak is newer and they've also had less access and time for vaccines, those places are showing an increase. We're going to get an update of this, this week. So this is based on data that's about a month old. So soon we're going to have a new view into how this deceleration or acceleration looks like, jurisdiction by jurisdiction. NUZZO: Great. Thank you. Maybe turn to you, Dr. Youde. You've been an important voice about the global dimensions of the monkeypox crisis. And I'm just curious where you think we are globally. And I referenced in introducing you that piece that you wrote on Think Global Health that I thought was—made a quite compelling argument about the role of WHO and where you see the response needing to go. Do you want to maybe elaborate on those points for people who haven't had a chance to read your article? YOUDE: Sure. Thank you for the question, and thanks for organizing this. I'm honored to be part of this event. And, picking up on some of what you were talking about and what Demetre was just talking about as well, we do see these inequities that exist, especially when we're looking worldwide. The World Health Organization did declare monkeypox a public health emergency of international concern. And while it doesn't necessarily come with automatic funding or programmatic resources, it does raise the profile. It does put this on the global health agenda and say: This is something we need to be paying attention to. In the piece I described it as the WHO's bat signal. We're sending out the message: This is something that we need to pay attention to. But one of the things I think is frustrating about the WHO response, and just sort of the global community's response to monkeypox in general, is that monkeypox isn't a new disease. This is a disease that we've known about in human cases since 1970. Laurie Garrett in her book, The Coming Plague, which came out in '94—which is one of the books I think a lot of us who are probably about a similar age read in our early, formative days as we were coming into global health and global health politics—she talks about it in that book. And if you look at the data that we have, we've been seeing increases in monkeypox cases in humans in countries where monkeypox was endemic for about the last decade or so. And so—but what really caught the international community's attention was then when it came to the Global North, when it came to the industrialized countries. And that helps to reinforce some of these questions about what is the nature of our real concern about global health? Is it about health in this very broad mandate, like the World Health Organization has as part of its constitutional mandate, to be this international coordinating body? Or is the sense that we, in the Global North, want to keep the diseases from the Global South coming to affect us? And there are similar sorts of issues when we're looking at vaccine equity and vaccine access, when we're looking globally. And, there have certainly been some problems here in the United States, getting access to the vaccine. But, I was able to get vaccinated against monkeypox. Yeah, I had to drive two and a half hours to Minneapolis to do it, but I was able to do it. And I was able to arrange it. People in countries where monkeypox is endemic have little to no access to these vaccines. And it raises some of the questions then, again, about how the international system and the global health governance systems that we have in place—how they can address some of these equity challenges? Because in many ways, outbreaks like monkeypox, they glom onto the societal and social cleavages that exist, and help to reinforce and exacerbate them, but also provide this opportunity for us to really put some of our ideals and our promises around social justice, around a cosmopolitan view of understanding that we are all healthier if we are all healthier. And really put those into practice, if we have the political and economic will to do so. And that's where—that's one of the areas where I get a bit concerned right now. I know we're all exhausted talking about COVID-19 and about monkeypox, and all of these sorts of outbreaks. Jennifer, I know you've been doing a lot of this. Demetre, obviously, you've been on the frontlines. I've been doing some of this work as well. But when we lose that attention, sometimes we lose then that motive—that momentum in the political system to try to address some of these challenges and these shortfalls that we have identified. So, I can be a critic of the World Health Organization, but I also recognize that the World Health Organization is a creature of its member states. And so, it's really incumbent upon the member states to really put some action behind their words. And to say: If we want to have a more effective response, we need to build systems that are going to be able to respond better than this. NUZZO: Thank you for that. It's a good segue to what I wanted to talk about next, which is the title of this webinar being about social justice. And those who've worked in public health, the notion that social justice has a role to play in reducing our vulnerability to infectious disease is quite clear. But I'm aware, particularly over watching—(laughs)—the national political debate over the last several years that those outside of public health may not recognize the connection between our vulnerability to infectious diseases and social justice. And they may be dismissive of the idea that public health authorities should be engaged in the work of social justice. So this is actually a question for you both. And maybe reflect on monkeypox or your long experience of other infectious disease threats that you've worked to address. And what would you say to folks that just don't understand why public health should be concerned with social justice, and what role do you think it has to play going forward? And maybe we'll turn back to you after Demetre. DASKALAKIS: Do you want Jeremy to go or do you want me to go first? NUZZO: Go ahead. YOUDE: Go for it. Go for it. I'll let you start. DASKALAKIS: All right. So I'll put my very strong HIV hat on, because that's sort of where I come from. And I'll start that this is a forty-one—a forty-two, almost, year-old lesson that I think we've seen play out over and over again, which is that really the social determinants of health are actually what drive infection. So there are countermeasures that can work. There's vaccines. There's drugs. There's pre-exposure prophylactics, post-exposure prophylactics. It doesn't matter. The social determinants are really what ultimately ends up blocking us from being able to implement the full vision of what we know we can from the perspective of medical technology and public health. And so I think that at the end of the day that implementation piece is so critical. So much technology can exist, so many interventions can be designed, but they sit on the shelf unless there's both the political and social will to move them forward. And so I think I should put that HIV hat there for a second, because in environments where there is less political and social will we tend to see HIV flourish. And in places where there is social and political will, we tend to see HIV not do so well from the perspective—or, in other words, we will do well because of less incidents and prevalence. So I think that sort of looking at that will is so critical. I'll give you a story from monkeypox which I think is really important, that is about the sort of CDC response. I got pulled in really early on, before the first case actually hit the United States. One of the very early conversations that we had with the response is that we need to expect that we're going to have inequities that are going to be a part of this. And I think that's based on lessons from COVID, and lessons from HIV, and lessons from so many other infections. I think we really worked to make equity the cornerstone of the response. But even when you do that, it is an all-of-society thing that needs to happen, and not just something that is mediated simply by a public health department or a public health agency. Over. YOUDE: And if I can take that public health hat and HIV hat that you had on, and I'll wear it myself. I got into this line of work through working on HIV/AIDS issues in Zimbabwe and South Africa, and seeing how those sorts of societal cleavages played a role, but then also how infectious disease outbreaks, and the spread of HIV was glomming into these other issues around democratization, around building societies that were going to be equitable, that were going to be able to fulfill the promises that governments had made to their populations. And seeing how a disease like this was thwarting that progress. So it's something that is not just unique to the United States. It's something that we see globally. From a very instrumental perspective we can say, look, public health is ultimately a weakest link public good. Everyone is still at risk, so long as risks still exist. So we need to reach out to those places which might have fewer resources, which might not have the same sorts of ability to implement these sorts of programs, because ultimately that's going to make us all healthier. And I think there's elements and an important role for those sorts of instrumental views of public health. But I also think about the recently passed Paul Farmer, and his notion of public health, especially his idea around the preferential option for the poor, which was kind of a double-edge sword. Because on the one hand he was saying, look, the people who are disenfranchised within societies, those are the people who are the most vulnerable to these infectious disease outbreaks. Those are the people who are at the greatest risk. But also, we need to think about our programs, we need to think about our interventions putting those people first, thinking about equity. Putting that not as an afterthought or something that we think about five, six, seven steps down the road, but it needs to be central, and it needs to be core. Because, again, if we're not taking equity seriously and we're not really putting this into everything that we're doing, then we're just reinforcing these sorts of divisions and, again, providing these opportunities and these outlets where diseases can thrive. And so, to just cosign what Demetre was saying we can have all the technologies we want. And I have all my criticisms about the way that the access to pharmaceuticals and drug interventions exist on a global level, and questions about compulsory licensing and all these sorts of things. Those are all important, but those are secondary in a lot of respects if we don't have the underlying core infrastructure in place. And that core infrastructure, even if it's not touching us in a direct way, does have an effect on our ability to stay healthy. DASKALAKIS: Could I—this is a fun one. Could I keep going a little bit longer on this? NUZZO: Please do, yeah. DASKALAKIS: This is a great, stimulative conversation on this. And along with what ends up being both the foundation of the issue as well as the deeper foundation, the way that all of these social issues interact with stigma, like I think we've seen in fast-forward with monkeypox. Like all the things that we saw with HIV and other infections and COVID—today, for instance—this is a really good example. So, we're giving the vaccines and right now they're going on people's forearms. Which means that literally some people will have a mark on their forearm. So talking about stigma—literally stigma. And so, we changed it so that individuals can elect to get the vaccine on their shoulder or on their back. So we have people who want vaccines but are saying, I don't want to be marked by this. I don't want to have the sort of—someone know that I am someone who's potentially identifying myself as part of a group at risk. And so it interacts exactly with the social determinants. Whether it's poverty, transportation, racism, all of it interacts in a way where these sort of more brass-tacks economic issues interact with these very profound stigma issues and create barriers where even if you do have great access—I'll give an example again. [The] Ryan White [program] is really great access for people for HIV medication, but we still don't have everybody in the country—(inaudible)—right? So why is that? It's partially access, but it's also that the systems are built to sort of maintain structures of stigma and structures of inequity that are really hard to overcome, even with things that provide access. NUZZO: So I was actually going to ask you about stigma. So thank you for segueing to it. And I seems to me that—and I don't have the HIV hat to wear, like you both do. But studying events that we typically think about in the field of health security—which is a field that sort of struggles to incorporate the forty-plus year lessons that HIV has learned—is that it is clear that stigma is an issue in nearly every single event. Any time we have particularly a new infectious disease, or something that's unusual, society seems to look for some group to blame. But what it seems, though, is that while there's an increasing recognition of the importance of stigma, it doesn't seem like we have great strategies for addressing it. And I guess I'm wondering, do you agree? And also, what practically can and should we be doing to address stigma? I really saw us struggle with this. I mean, we had a recognition of it as being important in monkeypox, but I feel that the absence of clear ways to deal with it really led us to struggle to talk about monkeypox, and who was at risk, and how people could protect themselves. So what should we be doing going forward not just for monkeypox but future threats, so that we don't get hobbled by—first of all, that we can minimize or tackle stigma, but also don't get hobbled by it? Whoever wants to chime in. (Laughs.) DASKALAKIS: So this is back to the HIV hat. This is the tightrope that we walk every day in HIV. And I think that the lesson actually—well, one of the first lessons that's important, sort of sitting on the government side of the world, is that government needs to lead, and governmental public health needs to lead, so that its messaging does not propagate stigma. That's very important. Because whether people like governmental public health or not, or have complaints about it, ultimately people do look to governmental public health—like CDC, local health departments—to really fine-tune their own messaging, and then translate that messaging not just to another language but translate it so the populations that people work with actually understand. And so I think monkeypox was actually a kind of exciting example, where from the very beginning of the response it was a how can we take an anti-stigma stance in how we messaged it? And so the balance really then depended on the data. And so that's what was really important. So it was starting with imperfect data, and as the data became more and more clear, making sure that the messaging evolved in a way that addressed what you were actually seeing epidemiologically without necessarily—without creating a scenario where you're pinning infection, a virus, on a population. Let me give you an example since, Jennifer, you say your HIV hat isn't as strong as ours. So in the '80s, when HIV started, before it was HIV it was gay-related immunodeficiency. So that lesson was the lesson that was so important in the work that we did with monkeypox, to start off by saying: This is a virus that can affect anyone. But we're seeing this virus more in this population. As opposed to saying: This is this population's virus. And so it's leading by that example. And it's one of those things that we can raise up and say: We have learned the lesson from this forty-two years ago, and we're not doing it this way again. And so with that said, I think that there's a lot of strategies that can address stigma. And a lot of that has to do with communications, using trusted messengers. So, that has been a really important part of this as well because, again, working in public health I would love if everybody listened to public health data. So providing good communications to individuals who are trusted messengers is really important. And also, part of the propagating stigma is also being clear about what data is, things that we fully know and things that we're still learning. Because that really allows that risk communication so that you don't over-select or too rapidly move a response into what population, as opposed to being broad. So as you learn more data—so, for us, our guidance started off in one place about safer sex and safer gathering. As we were seeing that this was not moving throughout the different populations, it got stronger and stronger. And we really started the conversation by saying that this is guidance that's going to change as we learn more. I think that we do have stigma mitigation strategies. But stigma's a stubborn thing. I'll give it over to Jeremy. YOUDE: Yeah, I would agree with everything that you said. And especially being—having that level of humility. We are still learning about this. Things are going to change. Things are going to evolve but building those sorts of trusting relationships. The other things that I would emphasize, and I think these complement what you were saying quite well, is empowering communities to speak to each other. I think one of the things that we've seen here in the U.S. around access to the monkeypox vaccine, and the relatively high rates of vaccination that we've seen, has been people talking to other people. Men who have sex with men talking to other men who have sex with men, and this becoming part of the conversation. Even if it is something at the level of, where were you able to get access to it? When supplies are limited. Just building that sort of awareness within a community can be incredibly important. I think it's also important to make sure that we do have targeted messages. Not blaming messages, but understand that the message that just says, everyone is at risk for HIV or everyone is at risk for monkeypox, ends up falling flat and doesn't really strike anyone. And so having that sort of targeted outreach plays an important role. But going back to this point about empowering the affected communities, one of the most powerful things that I think that I've seen in the work that I've done is looking at the Treatment Action Campaign in South Africa, and the work that they did, especially in the late '90s and early 2000s, with the T-shirts that just in huge, bold letters across the chest said: HIV positive. And just having people going out there, wearing those T-shirts. The image of Nelson Mandela wearing one of those Treatment Action Campaign T-shirts is just incredibly important because, again, it's helping to remove some of that stigma. It's getting people who are trusted, who are respected, coming into the conversation. OK, if he's involved in this, if he's saying this is an important issue, maybe this is something that I need to be paying attention to. But also just trying to make that sort of availability, so that people are willing to share their experiences, or talk about what's going on, or what worked, or what didn't work for them. Again, these all play really important roles. It's never going to be perfect. It's something that we do need to keep at the forefront when these sorts of outbreaks happen. And you see some of this in some of the broader conversation around even what we call diseases, the names that we use. The fact that there is a very strong move away from geographically located names for diseases, because we don't want to stigmatize those particular communities or people who happen to be coming from those areas. Even something like that can play a really important role in helping people to think, this is something that I need to take seriously if I'm in the United States, I need to take this seriously. Even though we're talking about something like monkeypox, which isn't a geographic designator but there aren't a lot of monkeys roaming around in Minnesota. But it's something that they should be taking seriously, because of these effects and these sorts of community-based responses that help to try to destigmatize things, encourage people to get access to vaccines, or treatments, or other sorts of options that are available to them, and start to have those conversations to empower communities. NUZZO: That's great. I'm going to turn over to questions. And maybe participants can start putting their hands up. But while that's happening and before I turn it over for that section of the conversation, one last question to you both. Which is, I am deeply worried that we respond to these events as these one-offs. We have an emergency, we get emergency funding, then perceptions of the emergency being over, the funding disappears, and it's gone. And we saw that happen with COVID, where the money went away and then states had to let go their pandemic hires. And guess what? They weren't there when monkeypox happened. So I guess the question is, how do we move away from sort of seeing these as just one-off emergencies, and moving towards a role where we create a durable sort of permanent system that's in place to snap into action anytime there's an event, which is happening—which we're seeing—these events are happening with an increasing frequency? YOUDE: I'll jump in first, Jennifer. It's like you're reading the paper that I've been working on throughout the event today. And that's part of my concern about WHO designating this to be a public health emergency of international concern, when we're talking about monkeypox or COVID-19 for that matter, is the emergency framework. Public health, when it's doing its job, we don't know about it. It's something that—where we're essentially trying to stop things before they reach that level of public consciousness, or stopping it really, really early in the process. And so the emergencies, they get the attention for global health but they don't necessarily get the long-lasting system. It becomes, like, OK, whew, we got through that. We can move onto the next thing, or we can just not pay attention to global health again until the next system comes up. But at a very fundamental level we have this organization. We have the World Health Organization, which has this constitutional mandate to act as this international coordinating body for health—cross-border health issues. And it has a smaller biennial budget than many large hospital systems here in the United States. So how is it going to be able to do that sort of work when it has so few resources? Plus, given the way that the WHO is funded, it only has control over about 20 percent of its budget. The rest of it is coming through these voluntary contributions, which are generally specified for specific purposes, which may or may not align with the purposes that the WHO itself would put in place. So I think that one of the things that happens there is it behooves us, it behooves the member states to actually—to put some diplomatic and political capital behind this, to actually move on this. I have no doubt that in a few years' time we will have some sort of after—some sort of response that will look at the response that WHO made to COVID-19. And it will bemoan the failures. And it will talk about all the things that need to change. And then it will gather dust on the bookshelf. And we will get similar sorts of things for monkeypox. And what we haven't had is a country or a group of countries, or some sort of person with high stature, really glom onto this and be like, yes. We need to do this. This is our potential roadmap for trying to address this in the future. I—nerding out in the global health politics world—I had this idea that someone like a Helen Clark, or an Angela Merkel, someone who knows international politics, who knows the systems, who has that sort of diplomatic experience, but also is concerned about issues around health, that could be the person who could help to inspire some of these actions, and could get the attention of world leaders in a way that civil society organizations often aren't able to do. Which is not to say anything bad about those organizations, just that there are structural problems getting the attention of world leaders, and having that sort of concentrated attention. So I think we—ultimately, we need a champion. We need a person, or a country, or a group of countries who are willing to really champion this, and go to the mat for trying to make these sorts of changes, so it isn't just emergency, after emergency, after emergency, but something that is going to be more long lasting, that is going to provide that sort of infrastructural support, and make sure that we aren't just lurching from here, there and everywhere, but actually can have some sort of coordinated response and something that is a bit more forward-thinking. But it's a challenge. NUZZO: Demetre, the bullets of your bio—(laughs)—are a list of the emergency, after emergency, after emergency. So I know you have first-hand perspectives of this. So any hope we can fix it? DASKALAKIS: Sure do. (Laughter.) So, my perspective may be very domestic, but I actually think it's not. I think when I start talking, I think it's going to seem as if there's also infrastructure that needs to be leveraged internationally that's similar. Which is, I always think about what actually worked. And so one of the things that I think we're seeing over and over again, whether it's COVID, or monkeypox, or other outbreaks, is leveraging systems that already exist, and really figuring out how to support those systems during peacetime as well as wartime, so that it stays warm for a response. And that's a very public health—it's a very sort of operational, public health example. So I'm talking HIV. I'm talking chronic infections. I'm thinking domestically, we have this excellent—I think the HIV Epidemic Initiative, it's not nationwide yet. It hasn't been resourced to do that. But, if it were, that is a really sort of important way to be able to create and maintain an infrastructure. So thinking about sort of chronic diseases like viral hepatitis, having an infrastructure that could potentially lead to curing more people with viral hepatitis creates a system that then could be used for care and other public health delivery of countermeasures. So thinking about things that—what can we do to sort of do our peacetime work, which is around chronic infections like virus hepatitis and HIV, and what can we—and STIs, which are out of control in the United States, mainly because they're under-resourced—but what can we do sort of to maintain sort of those systems, so that when we flip the switch from peacetime to wartime that we can pivot those resources to do the work? I'll give an example from the research universe—monkeypox, as an example. Right now, there are studies that are going on for monkeypox vaccines and for monkeypox therapeutics. And they're built on the networks of HIV investigators. So, HIV Vaccine Trials Network and AIDS Clinical Trials Group are currently the people that are doing those studies. And sort of research funding potentially being a bit more flexible, that pivot is possible. But what if we had similar models sort of in the operational world of public health, where you have sexual health clinics or STD clinics that are doing HIV/STD work during peacetime, but can flip into monkeypox vaccines and testing in wartime? And so it's investing in a chronic infrastructure to be able to make it translatable into an emergency response, in a nimble way, I think is really important. And of course, I back up Jeremy. That idea of political will and leadership is really important in making sure that this sort of moves forward in a way that works. But, I mean, I say this domestically, but then one can conjure PEPFAR in terms of an infrastructure that works. So that—they have been leveraged. And so what if we worked harder to make sure that they were resourced adequately during the peacetime, so that during wartime they flip and are flipped more effective? And by the way, that HIV positive T-shirt has influenced my career, Jeremy, in terms of seeing people who were willing to put on a shirt that really works against stigma. My favorite being Annie Lennox, who I met with that T-shirt on, and I was very excited, as a fan. But definitely an important thing to reclaim that stigma. Jennifer, thank you. YOUDE: And if I can build on what Demetre was saying, think about the Ebola outbreak in West Africa in 2014, and the cases that popped up in Nigeria. That led to all sorts of concern. Now you've got someone who has Ebola in Lagos, a city of twenty million people, and just not a city that necessarily has the sort of infrastructure in place that you're going to think, oh, we're going to be able to contain this. But they were able to repurpose existing programs. They were able to use measles control programs and other sorts of programs. And, using the word that we have all become way too familiar with over these past two and a half years, they pivoted, turned that into doing the surveillance and doing the contact tracing for Ebola, and were able to stop the spread, and being able to prevent that from spreading rampantly throughout one of the largest cities in the world. And I think that's the sort of thing, you know? If we have these sorts of structures in place, we can adapt them. Even if they are for one purpose, they can be adapted for other purposes. And so it's not that we need to recreat the wheel each time, it's that we need to figure—we need to make sure that we've got enough wheels out there, essentially. DASKALAKIS: And that goes for surveillance. Maintaining good surveillance systems for chronic things means that when an acute thing comes up, that good surveillance already exists there. So not only for an operation, but also for being able to understand what's happening with the threat. I like to call it keeping the system warm, if you think of sort of the stuff that's happening. So when you have to heat it up, you're not starting from—it's not a TV dinner you're taking out from frozen. It's thawed already. You can move quickly. NUZZO: It's really hard to build capacities in the midst of an emergency. So thank you for those thoughts. I am going to give others a turn to ask questions and turn it over to the question-and-answer session now. OPERATOR: Thank you. (Gives queuing instructions.) Our first question comes from Mark P. Lagon from Friends of the Global Fight against AIDS, Tuberculosis, and Malaria. LAGON: Hi, there. Thank you for this really thought-provoking forum. I come from a perspective working in the health field, but also background in human rights. I was an adjunct senior fellow at CFR, and president of Freedom House. I wonder, to take some of the points that Jennifer Nuzzo has been making and posing to you, to move to pandemic preparedness. If you have—we've seen that AIDS confronts one with very clear human rights and equity issues, particularly for stigmatized populations. You have a kind of a reprise with monkeypox. There was a lot of discussion about in terms of the impact of COVID and equity on vaccines. As the international community has moved to form a fund housed at the World Bank, how do you embed preparation for pandemics to have a human rights or social justice perspective? Activists really had to push hard to get two voting seats for civil society on the governing body of that fund. Thank you. NUZZO: Anyone want to take that on? (Laughs.) YOUDE: Sure. I'll offer a few thoughts. I think this is something—again, this is something to be thinking about at this early stage. As these sorts of systems are being designed, as they're being set up, keeping these sorts of elements important and at play. But I also think it's important to make sure that there are multiple channels for this communication to happen. That there's one thing to talk about formal board seats, and those are obviously important to have people at the table for these pandemic financing facilities through the World Bank and other sorts of organizations. But also make sure there are other opportunities, because new organizations may pop up. They may change. Depending on the particular circumstance or the particular outbreak that we're talking about, there may be other groups that are being mobilized and being affected by this. And so, there needs to be a certain level of nimbleness that needs to go into this. I think it's also something that puts a lot of—we need to put pressure on our leaders to really put their promises into action, to make sure that this isn't just something that we have as a tick box exercise. Oh, yes, equity is important, we need to address this. But actually, that there is this ongoing pressure and this sort of check of what are we actually doing here? Are we reaching out to these communities that are being affected? How can we better do this? And so I—again, there's an interesting moment right now that we can hopefully seize to make sure that this is something that really does get instantiated within these systems. And I hope we don't let that moment pass. I hope we don't decide to just we'll go back to existing systems. Because that's the other thing that goes along with this. It does challenge the status quo. It does challenge the sorts of standard operating procedures that we have in these organizations. And that can be challenging. That can be a difficult sort of conversation to have. And we have to be willing within our international organizations and other sorts of responses, we have to be willing to have those conversations. We have to be willing to challenge ourselves and to criticize ourselves, and to then make changes that are going to be effective. LAGON: Thank you. DASKALAKIS: I don't have almost anything to add to what Jeremy said. I think there really—again, the political will is important. And just we've all experienced that U-shaped curve of concern, right, where when things are very exciting everyone is very worried and engaged, and then when it fades away, resources fade away. And what that means is the infectious disease comes back. And so it's really—whether it's the same or a different infectious disease, sort of keeping that momentum and having it really come both from the political piece, from organization, but also from the side of advocates and activists is really critical to keep the—to keep the energy moving and the momentum moving. We have to make sure that we come to a better place. Every event, you learn more. And so I think that even if we take a quantum leap in what preparedness looks like, whatever the next event will challenge that level of preparedness and will require us to then—to really develop systems that are—that are updated based on the experience. So I think moving the needle anywhere, but moving it in a coordinated way because of that will and that strategy is the most we could hope for and the most we should expect. Or the least that we should expect, the minimum, of being able to move to a place where we have something that is better than how we found it, and potentially more resilient in terms of a—monkeypox is minor compared to COVID, after COVID. NUZZO: Yeah. I mean, I think the more we have these events the more we learn, though it does feel to me a little bit like the more we have these events, the more we learn the same things over and over again. (Laughs.) And particularly when we're talking about these inequities. And Jeremy pointed out about the stark inequities in terms of who's able to access vaccines in the globe. And that was clearly something that we saw throughout much of COVID-19, still see it today. We saw it during the 2009 H1N1 pandemic, in terms of who had vaccines and who didn't. So I guess the question—and I recognize that we have just about ten minutes left, and the CFR rule is we always end on time. So I'm going to—(laughs)—I'm going to be aggressive about that. But just on that point what do we need, I think, to put into place? We talked about how there's a pandemic fund now, which is important. But aside from money, and maybe it's just money, what else do we need to kind of create structures to address these inequities globally? Given, Jeremy, you also made the important point about—I've been struck by how hard it's been to contain monkeypox here in the U.S. But let's say we're successful, we're still going to have challenges as the virus continues to circulate. So we need to make progress globally. And we need to have systems in place such that every time these emergencies happen, we don't keep learning these same lessons over. So maybe just two or three minute each, your takeaways on what you would do to fix these problems if you were deemed in charge of the world. YOUDE: A little new world, just like that. Money is obviously important. The amount of money that we spend on development assistance for health has gone up dramatically since the early 1990s, but it still pales in comparison to the level of need. So there is just a basic resource need. The second is that we need to make sure that systems that we are building are not for specific diseases, but are things that can be flexible, things that can be adapted. We don't want to just say: Now we're going to set up all these monkeypox surveillance systems, when that may or may not be what is going to be the next big outbreak. So we need to have things that are going to be able to be flexible like that. Third, we need to have—we need to have a better sense of just our—I guess our international community's willingness to engage with global health. We have the international health regulations. So we do have an international treaty that's supposed to govern how states respond to infectious diseases and their outbreaks. But the willingness of states to abide by that varies quite dramatically. And so we need to have a big of a come-to-Jesus moment about what are we actually willing to do, when push comes to shove? And then last thing I'll say is that I do think we need to have a conversation around access to pharmaceuticals and vaccines and other sorts of medical interventions like that. Because we know that there are inequities, and we know that oftentimes the communities that have the least access are the communities that have the highest rates of incidence or are in the most need of these sorts of things. And our structures are not really well designed for getting people access. Even though there are things like COVAX, even though there are things like PEPFAR, and all these other sorts of programs, which have done tremendous work, they are still falling short. And so we need to—we need to have a better sense of what—how do we actually put these sorts of things into practice? How do we actually make sure that these scientific breakthroughs that are so invaluable are reaching all the people that need to be reached? DASKALAKIS: Ditto, I'll start off. So that makes my job a little bit easier, because I think what Jeremy said is really important. I'll say again, I think in my hierarchy the first and most important thing is consistent political will, because I think that that then drives a lot of what happens beyond that. So I think that that really jives really well with what Jeremy said, in terms of that sort of commitment. Money is very important, I think, but it is not the only thing that drives us into preparedness. So I think that having that commitment. I also would like to think about that investing the money in things that keep the system warm. So I'll go back to that sort of statement, or like thinking about investing in the diseases that we still haven't finished. We still are working—we've got HIV, we have hepatitis, malaria internationally that we're worried about. There are a lot of areas that we could invest to create systems that are infrastructures that keep it warm for operation for pandemic. I cannot say it loud enough that what Jeremy said about flexibility is right. You can't really build the infrastructure on chronic disease if it's not flexible to move to another acute event. So it needs to be something that is both creates and maintains the infrastructure, but also has the ability—everyone's favorite word today—to pivot into the emergency response zone. So very important. I think also workforce and data. I think that it is important to remember that we talk about giving patients trauma-informed care, but we need to give our workforce trauma-informed care. COVID has been hard. Monkeypox has been hard. Our next challenge will be hard. And sort of how can we support the workforce and then also continue to mentor it to be able to do the work? Data also is so important. A commitment to share data, and to have data that is accessible for decisions, even if it is imperfect. And then finally, the realization—and it goes back full circle, Jennifer, to your first question—about our—or, maybe second question—about the social determinants. There's only so much that public health can do. There is an all-of-society need to address the core drivers of so many of the inequities. We can't solve everything through public health. We can get closer to health equity, but ultimately the goal is that as you access is really to go into social justice, which is not just public health but really an all-of-society endeavor to try to improve the environment so that we don't have fertile ground for these pandemics to blossom and grow. NUZZO: Thank you. There's a question that just popped up in the Q&A box. And we just have a few minutes. It's about the privilege of good information and how we address misinformation and disinformation, which likely leads to fragmentation. I will just chime in, having done a lot of communication over the past two years, I think that this is not a problem that public health can solve. I actually think the drivers of this are much, much larger. And I think we need an all-of-government approach to this that includes the potential regulation of the platforms. But I'm curious if you all have any quick comments to add to that. DASKALAKIS: I mean, I just agree with you. (Laughs.) It's definitely much bigger. There are things we can do, like monitor social media and make sure that our messaging is one way. But ultimately this is an issue that's bigger, that requires not just the public health lens to address. YOUDE: And, at the same time, we also can recognize that those trusted outlets, those can be really important tools. So, churches in sub-Saharan Africa played a really crucial role in many parts of helping to decrease HIV stigma, helping to get access and information out there about testing, about protection, about these sorts of things. I mean, that can also be the flipside, though. If you got these trusted sources that are peddling this misinformation, then it becomes this much bigger issue that goes beyond what public health can do. So I guess it's—part of it is just figuring out where those allies exist, be they in government or outside of the government, and what sorts of connections they might have with populations. DASKALAKIS: And to your earlier point about building those connections prior to events, so those relationships exist and you're not trying to forge them in the midst of a crisis. NUZZO: Well, really, thank you both. I wish I could appoint you both in charge of the world, because if I was asked who should be in charge of the world you would both be on the top of my list. But I am very glad that you continue to do the work that you do and contribute in important ways. And have both been really guiding voices as we continue to experience these events. So thank you very much for that, and really thank you to our participants for attending and the thoughtful questions. FASKIANOS: I second that. Thank you all. And we appreciate your taking the time to do this. I hope you will all follow their work. For Dr. Daskalakis, you can follow him at @dr_demetre. Dr. Youde is at @jeremyyoude. And Dr. Nuzzo is at @jennifernuzzo. Pretty easy. So we also encourage you to follow CFR's Religion and Foreign Policy Program on Twitter at @CFR_religion and write to us at outreach@CFR.org with any suggestions or questions. We want to help support the work that you all are doing. And we hope you will join us for our next Religion and Foreign Policy Webinar on the Politics of Religion and Gender in West Africa, on Tuesday October 11 at 12:00 p.m. Eastern time. So thank you all again for being with us, and thank you for your public service. We appreciate it.

Dr. Jennifer Nuzzo leads the Pandemic Center at the Brown University School of Public Health; she was initially hired for the role by Dr. Ashish Jha, who is now the White House Coronavirus Response Coordinator. Dr. Nuzzo tells hosts Mark Masselli and Margaret Flinter that COVID remains a fairly significant health threat, especially in terms of possible variants, but we're not in the same situation we were two years ago. She reacts to President Biden's recent statements about the state... Read More Read More The post How Will We Know When the Pandemic is Over? Brown Univ. Pandemic Center Director Explains appeared first on Healthy Communities Online.

Fr. Edward Looney speaks with Anna Nuzzo about her music ministry that has brought her to the Mystical Shrine in New York and the work she has done with Jeannie Ewing and the Marians of the Immaculate Conception. Fr. Looney and Anna then talk about a pilgrimage opportunity they are offering to Belgium beginning on Memorial Day 2023 through June 9, 2023. Listen to Anna's music and her reflections about ministry in this interview! Learn more about the pilgrimage: https://app.nativitypilgrimage.com/trip/?trip=72441&fbclid=IwAR37BcN_PeOXZkrxVoWvyitSGOga9dWQUmpCvDOBAOJAXk4gsJuZmYSVFOw (https://app.nativitypilgrimage.com/trip/?trip=72441&fbclid=IwAR37BcN_PeOXZkrxVoWvyitSGOga9dWQUmpCvDOBAOJAXk4gsJuZmYSVFOw) Anna on the Living Divine Mercy Show: https://youtu.be/V48017aLta0 (https://youtu.be/V48017aLta0) Our Lady of Ghent Altar Piece: https://artsandculture.google.com/asset/the-ghent-altarpiece-virgin-mary-hubert-and-jan-van-eyck/mQE3bnCJ1TJRjg?hl=en (https://artsandculture.google.com/asset/the-ghent-altarpiece-virgin-mary-hubert-and-jan-van-eyck/mQE3bnCJ1TJRjg?hl=en) Anna's Website: annanuzzo.com (annanuzzo.com) Get your holy socks from Sock Religious: https://www.sockreligious.com/?rfsn=5170834.c28065 (https://www.sockreligious.com/?rfsn=5170834.c28065) Buy Fr. Edward's book How They Love Mary from Sophia Institute Press: https://www.sophiainstitute.com/products/item/how-they-love-mary (https://www.sophiainstitute.com/products/item/how-they-love-mary)

What is a median? How about an interquartile range? Don't even get me started on how to define a p-value. These statistical concepts are hard to grasp for your average statistics student, but imagining how these types of definitions translate into American Sign Language is a whole other ballgame. That is the focus of this episode of Stats+Stories with special guest Dr. Regina Nuzzo. Dr. Regina Nuzzo is a freelance science writer and professor in Washington, DC. After studying engineering as an undergraduate she earned her PhD in Statistics from Stanford University. Currently, she's teaching statistics in American Sign Language at Gallaudet University, the world's only liberal arts college for deaf and hard-of-hearing students. Dr. Nuzzo is also a graduate of the Science Communication program at the University of California-Santa Cruz. Her science journalism specialties center around data, probability, statistics, and the research process. Her work has appeared in Nature, Los Angeles Times, New York Times, Reader's Digest, New Scientist, and Scientific American, among others.

7/21/22 6am CT Hour Glen and Sarah chat about mullet contests and bad haircuts as a kid. Jason breaks down what the Family Security Act is and why its important to support families so that they don't feel pressure to abort their children for economic reasons. Anna shares about her most recent projects including writing music for The Miracle Hunter and a Children's Entrustment to Mary song.

What did COVID-19 teach us about pandemic preparedness? How concerned should we be about monkeypox? Download the latest episode of the Public Health Out Loud podcast to get the answers from Dr. Jennifer Nuzzo, an epidemiologist, pandemic preparedness expert, and the director at the new Pandemic Preparedness Center at the Brown University School of Public Health.  Co-hosts Dr. Jim McDonald and Dr. Philip Chan talk about their experiences as local public health officials throughout the COVID-19 pandemic, and ask Dr. Nuzzo what Rhode Island, the nation, and the world could do to better prepare for another pandemic.  

TENORISSIMO His magnificent voice elevated me when I saw him perform, bringing me to tears. Tenor John Ken Nuzzo is celebrated by classical enthusiasts worldwide and here in Japan for his numerous operatic achievements and brilliant performances. A graduate of St. Mary's International School, John studied at Chapman University under the acclaimed Patrick Goeser. John speaks of his music studies and how classical music is about "breathing" while sprinkling melodious renditions of classical and operatic phrases. When John achieved the high C, Patrick assured him that he was ready for the journey as an operatic performer. www.jkn-tenorissimo.com

Die Künstlerseelsorge im Bistum Passau präsentiert im Exerzitien- und Bildungshaus spectrum Kirche auf Mariahilf in Passau seit Freitag (25.03.2022)die Ausstellung: “LA SANTA CRUS DI CERVENO“ von Giacomo Nuzzo. Im Interview spricht der Organisator und Leiter von spectrum Kirche Dr. Bernhard Kirchgessner über die Ausstellung. (Bild: Giacomo Nuzzo / Spectrum Kirche)

Meet Vinny, Vinny is the Founder and CEO of Stress Undone. This is a long delayed episode that you must listen to. Earlier on the show I got amazing guests that talk about Nutrition, Fitness, Diet, Exercise, mindset and all separately, but this episode gives you a complete different point of view since stress will be included in each and everyone of them. Did you know that working out is stress itself? Did you hear about Nutritional Stress? All those things are real!! Did you know that over-working out can actually add more negative stress to your body? Vinny emphasizes on the importance of Healing in before Healing out, but what does it mean? You are always taught to eat healthy, workout, etc. you have heard all of those a million times but there is more to it all. There are so many truths shared in this episodes that no one really talks but Vinny does in this episode which is so refreshing. This episode will defiantly open you up to a whole new way of looking at things. Connect with Vinny on Linked In: https://www.linkedin.com/in/vinnynuzzo/

In Episode 3, Brendon and Stefan sit down with a man who played a major role in helping them on their personal journeys of recovery, and countless other Jaywalkers and addicts in the Roaring Fork Valley over the past 25 years: Kim Nuzzo. Kim was a clinician at Jaywalker for many years and shares a wealth of knowledge and experience with how he navigated his own journey in recovery and assisted so many others in theirs. 

In this episode, we sit down with Dr. Alexandre Nuzzo and discuss a recent review in the Lancet Gastroenterology Journal entitled, “Prevention and Treatment of Nutritional Complications After Bariatric Surgery”. Dr. Nuzzo is an expert in intestinal failure and is active in managing the clinical care of a novel GI Stroke Center in France treating patients with mesenteric ischemia. He is also the first international guest on the Emoroid Digest Podcast. Time Stamps: 00:00 - 13:00 Introduction  13:00 - End - Discussion of Review Paper   Link to Lancet Article  -https://pubmed.ncbi.nlm.nih.gov/33581762/   Host: Dr. Chuma Obineme (GI Fellow) –  https://twitter.com/TypicallySilent    Co-Host: Dr. Jason Brown - https://med.emory.edu/directory/profile/?u=JMBROW2    Post-Baritatric Surgery Nutrient Complications Visual Abstract - https://twitter.com/emorygastrohep/status/1400127488559300614?s=28   Link to the Emoroid Digest Website - https://med.emory.edu/departments/medicine/divisions/digestive-diseases/education/emoroid-digest.html   

Bobby and Afdhel are joined by conceptual artist and provocateur Hank Willis Thomas with his For Freedoms colleague Emma Nuzzo. We hear how they work to turn traditional ad-space into provoking art pieces, designed to inspire civic discourse, in the hopes of uniting a polarised nation. We believe that business and culture can be forces of good. But creators and entrepreneurs alike are still struggling to find the right model that allows them to impact real social change. In this series, Bobby Jones and Afdhel Aziz sit down with an extraordinary lineup of luminaries from the worlds of fashion, film, art, music and activism, who all believe in using business and culture as forces for good. In each episode, you'll learn how bold creative actions can change the world for the better through interviews with the trailblazers who are doing it every day. Recorded in the inviting Soho House in 2018, this podcast series delves into many unique stories and the one thing they all have in common – the desire and the courage to transform our world for the better.

So you've been vaccinated. And now you're hearing that you could get infected? Or be contagious? Andy gets to the bottom of this when he calls up one of the clearest explainers he knows, Johns Hopkins epidemiologist Jennifer Nuzzo. They discuss why although you may get infected with SARS-CoV-2 eventually, vaccinated people are still unlikely to get COVID-19, and what that means. Plus, Andy breaks down the new recommendation about boosters.   Keep up with Andy on Twitter @ASlavitt and Instagram @andyslavitt.    Follow Jennifer @JenniferNuzzo on Twitter.    Joining Lemonada Premium is a great way to support our show and get bonus content. Subscribe today at bit.ly/lemonadapremium.    Support the show by checking out our sponsors!   Click this link for a list of current sponsors and discount codes for this show and all Lemonada shows: https://lemonadamedia.com/sponsors/  Throughout the pandemic, CVS Health has been there, bringing quality, affordable health care closer to home—so it's never out of reach for anyone. 

Learn more at cvshealth.com.   Check out these resources from today's episode:    Read more about the new recommendation that all Americans get booster shots 8 months after their second dose: https://www.nbcnews.com/health/health-news/u-s-announces-plan-offer-boosters-all-americans-starting-late-n1277059?cid=sm_npd_nn_tw_ma The New York Times has compiled data on breakthrough infections leading to hospitalizations and deaths for 40 states and Washington, D.C. here: https://www.nytimes.com/interactive/2021/08/10/us/covid-breakthrough-infections-vaccines.html Find a COVID-19 vaccine site near you: https://www.vaccines.gov/  Order Andy's book, Preventable: The Inside Story of How Leadership Failures, Politics, and Selfishness Doomed the U.S. Coronavirus Response: https://us.macmillan.com/books/9781250770165    Stay up to date with us on Twitter, Facebook, and Instagram at @LemonadaMedia.    For additional resources, information, and a transcript of the episode, visit lemonadamedia.com/show/inthebubble. See omnystudio.com/listener for privacy information.

Rachel takes us on a journey into one of North America's savannas dominated by oak trees. They provide shelter and food for a variety of different animals and (surprise) are critically endangered. One of the biggest causes of decline is a change in land management when European settlers pushed out indigenous land caretakers. This episode is a little long but worth the ride. Primary Sources: Be sure to check out photos and more at our site! Gucker, Corey L. 2011. Quercus macrocarpa. In: Fire Effects Information System, [Online]. U.S. Department of Agriculture, Forest Service, Rocky Mountain Research Station, Fire Sciences Laboratory (Producer). [2021, August 2]. Savanna Oak Foundation, http://www.oaksavannas.org/ Nuzzo, V.A. 1986. Extent and status of Midwest oak savanna: presettlement and 1985. Natural Areas Journal 6: 6-36. McPherson, Guy R. 1997. Ecology and Management of North American Savannas. University of Arizona Press, Tucson.(edited) Contact Website Facebook Twitter info@grasslandgroupies.org

The Future of Public Health: Why We Should All Be Concerned

En esta segunda temporada tenemos invitados especiales que nos ayudaran y nos retaran a ser mejores. En este primer episodio tenemos el grato honor de tener a Tito Cuellar quien forma parte del liderazgo de Legendarios; un movimiento para formar el caracter de los hombres y Lino Di Nuzzo, actor de Disney.

Live events are finally coming back this summer! Everything from backyard bbq's to weddings to birthday celebrations and more are coming back alive in the area. Musicians are getting hired and so are DJ's! We chat with a local favorite,  Leigh Richardson who is a solo acoustic act and most recently formed a trio called Rising Tide. Rising Tide is rock trio that plays everything from covers of Bob Seger to Tom Petty and Dave Matthews to Jack Johnson! One of his best cover songs is ELP's "Lucky Man"! We chat about the evolving trio group and why it is an advantage to only have three guys instead of a whole band when it comes to events. In the second segment we chat with mobile DJ's Jimmy "Jams"  Nuzzo  and Sean "Big Daddy" McKee! They give us the lowdown of how events especially weddings are shaping up this season after a rough year with the pandemic! They discuss the current state of events along with "The Zman" Matt Zako the host of The City's Backyard and local radio personality and DJ himself!   The Zman chats with Jimmy Jams and Big Daddy  about  what separates them  apart from any old DJ and why the art of  dancing  and having a good time is the most important way to celebrate!

This week, we talk with Gina Nuzzo-Vienneau about the grief she experienced in losing her son, River. We celebrate the lessons he taught her in his few short years on this earth, the unified grieving process she shared with her husband, and how her spiritual connection with her son pushes her forward. Please note: This episode discusses the death of a small child which some may find triggering.   Follow Gina's journey on Instagram at https://www.instagram.com/consciousmama_/ Follow Emotional Duct Tape at: Facebook: https://www.facebook.com/EmotionalDTPod/ Instagram: https://www.instagram.com/emotionalducttapepodcast/ Tikok: https://www.tiktok.com/@emotionalducttapepodcast Email us with questions or comments at emotionalducttape@gmail.com

Micro resilience Part IV: increase your fuel efficiency The micro-resilient concept this week comes from Bonnie St John's 4th framework: increasing our body's fuel efficiency. You can increase your fuel efficiency in the way you approach drinking water.  Research tells us that our brain is made up of 70% water, the rest of the body is made up of 60-65%. Water plays a key role in how most of our body systems function. Some of the symptoms that can easily be due to dehydration: ·        A dry mouth and the sensation of being either thirsty or hungry ·        Generalized body aches and muscle cramps ·        Dry skin that seemed more prone to irritation ·        Decreased ability to focus well – even during high energy times ·        Multiple non-specific coughs and colds How do you stay hydrated in a crisis?  How you plan to have access to water may need to be adjusted to how you are going to stay hydrated while wearing a mask, and for some, gloves and gown. How are you going to stay hydrated if it is not appropriate to keep a bottle of water with you in your work environment? Do you have influence as a leader within a work environment: ·        where you work specific blocks of time where you musts wear masks? ·        within the healthcare environment with those who must wear full PPE? ·        with those who work directly under the sun? ·        with those who are working from home? During this global pandemic we have come face to face with the immutable truth that human safety is critical to our economic well-being. How do you define human safety in the workplace? How does the long working hours culture fit into the definitions of human safety that are emerging as a result of this pandemic? The purpose of this focus on a micro moment in resilience is to find what works best for you. How can you plan ahead for each day so that you are drinking enough water to be at your best – to think your best and to respond at your best. How can you influence those around you?  Resources: Candore, Giuseppina & Colonna-Romano, Giuseppina & Balistreri, Carmela & Carlo, Daniele & Grimaldi, Maria & Listì, Florinda & Nuzzo, Domenico & Vasto, Sonya & Lio, Domenico & Caruso, Calogero. (2006). Biology of Longevity: Role of the Innate Immune System. Rejuvenation research. 9. 143-8. 10.1089/rej.2006.9.143. Cleary, M. A., Sitler, M. R., & Kendrick, Z. V. (2006). Dehydration and symptoms of delayed-onset muscle soreness in normothermic men. Journal of athletic training, 41(1), 36–45. St John, B. (2017). Minor Shifts for Major Boosts in Focus, Drive, and Energy. Hachette, UK. n.d. (2017). How dehydration impacts workplace productivity. Premium Waters Inc. Retrieved from https://premiumwaters.com/blog/dehydration-impacts-workplace-productivity/ (https://premiumwaters.com/blog/dehydration-impacts-workplace-productivity/) Jy Ong, J.,et al. (2020). PPE- associated headaches increase among health care workers amid COVID-19. Headache. Retrieved from https://www.healio.com/primary-care/practice-management/news/online/%7B01a63c64-82a8-4db9-a272-48c962445c60%7D/ppe-associated-headaches-increase-among-health-care-workers-amid-covid-19 (https://www.healio.com/primary-care/practice-management/news/online/%7B01a63c64-82a8-4db9-a272-48c962445c60%7D/ppe-associated-headaches-increase-among-health-care-workers-amid-covid-19) Wittbrodt, M., Millard-Stafford, M. (2018). Dehydration Impairs Cognitive Performance. Medicine & Science in Sports & Exercise: 50; 11; pp...

Is flexibility testing valid? What evidence is it even founded on? Should it be retired as a major component of physical fitness? Should we de-emphasize static stretching in exercise prescriptions? We discuss these things and more with Dr. Jim Nuzzo, who recently wrote a thought-provoking paper on the topic.  Connect with Dr. Jim Nuzzo: Twitter: @JamesLNuzzo ResearchGate: http://bit.ly/36IEtTJ Google Scholar: http://bit.ly/35FhRSQ Here is the paper that we discussed on the show: http://bit.ly/2QFBG8e Follow Quinn, John, Jared, & ClinicalAthlete on IG: @quinn.henochdpt @rebuildstrongeronline @jaredmaynard_pt @clinicalathlete Check out details about the upcoming CALU Summit in September 2020! www.calusummit.com You can find other resources on athlete health and performance posted on the ClinicalAthlete website for free, inside of the ClinicalAthlete Forum, at our courses, and through ClinicalAthlete Coaching! https://www.clinicalathlete.com

An innovative golf course is about to open north of Houston. We visited Grand Oaks Reserve with architect Mike Nuzzo, whose routing has a brand new spin on the traditional golf course community. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.